Endeavoring to provide highest quality and most convenient Interferon
Ø Best administration method – subcutaneous injection, improves clinical efficacy
Brief Prescribing for:
Recommended dosage and administration
Chronic hepatitis B
3-6MIU once daily or three times a week, administered subcutaneously, continuously for 6 months.
Acute and chronic hepatitis C
3-6MIU once daily or three times a week, administered subcutaneously, continuously for 12 months.
Chronic myelogenous leukemia: 3-5MIU/m2 once daily administered subcutaneously, also can be administered simultaneously with chemotherapy medicines such as hydroxycarbamide or Ara-C. All patients with complete hematological responses should continue injection every other day. The cytogenetic changes may be achieved in 9-10 months.
Hairy cell leukemia: 2-8MIU/m2 administered once daily, continuously for not less than 3 months. The response is achieved usually after 1-2 months of treatment.
Renal cell carcinoma: 6MIU administered subcutaneously three times a week, continuously for 8 weeks, simultaneously with chemotherapy.
Multiple myeloma: 3-5MIU/m2 administered subcutaneously three times a week, simultaneously with chemotherapy such as VMCP.
Malignant melanoma: 6MIU administered subcutaneously three times a week, continuously for 1 month, simultaneously with chemotherapy.
Non-Hodgkin's Lymphoma: 3-5MIU/m2 administered subcutaneously three times a week, simultaneously with chemotherapy such as CHVP; 8-12 weeks as one treatment course, The treatment should be maintained for 12 months unless patient’s illness is exacerbated rapidly or severe intolerance occurs.
Herpes zoster: 1MIU administered subcutaneously once daily, continuously for 6 days. And taking acycloguanosine orally at the same time.
Condylomata acuminata: 1-3MIU administered subcutaneously each day, continuously for 4 weeks. Another method is 1MIU injected intralesionally each time, while simultaneously treating with laser or electrotherapeutics.